the role of microglia in the pathophysiology of icans following cd19 car-t therapy
Published 4 months ago • 137 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
3:33
the growing role of machine learning in hematological oncology
-
0:38
the functional role of cd4- and cd8-expressing t-cells in aml
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:12
the evolving role of allosct in treatment of lymphoma
-
1:13
investigating the effect of chip mutations in microglial function and alzheimer’s disease
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
50:56
chip and ccus, precursors to mds
-
22:35
haploid induction and breeding : by dr. william rooney
-
3:11
blood 9- lymphocytes
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
1:37
the role of ctdna in hodgkin lymphoma
-
3:58
extended follow-up of glofitamab monotherapy in r/r lbcl: durability of cr and likelihood of crs
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:04
the future of cll therapy
-
1:01
update on the cll treatment landscape
-
0:59
the role of radioimmunoconjugates in aml treatment: insights from the sierra trial
-
2:31
relevance trial analysis: investigating the impact of lymphocyte/monocyte ratio on patient outcomes
-
2:31
mini-hyper-cvd ino followed by blina consolidation for r/r all